Search results
Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
Zacks via Yahoo Finance· 20 hours agoAmgen (AMGN) beats first-quarter 2024 estimates for earnings and sales. Amgen is "very encouraged"...
Doctor explains science behind AstraZeneca’s admission Covid jab can cause blood clots
The Independent via Yahoo News· 3 days agoA doctor has explained the science behind AstraZeneca’s admission that their Covid jab can cause...
Health Secretary accused of snubbing alleged AstraZeneca Covid jab victims
Daily Telegraph· 5 days agoPeople who were injured after being given the Oxford-AstraZeneca vaccine have accused the Health...
AstraZeneca, Daiichi look to broaden Enhertu use again with new study data
BioPharma Dive via Yahoo Finance· 5 days agoThe drug benefited people whose tumors have “ultralow” levels of HER2 protein, a result that could...
Mendez: Price caps on inhalers won’t do enough
Boston Herald· 7 hours agoPresident Biden recently held an event to celebrate that three major drugmakers announced they are putting a $35 monthly out-of-pocket price cap on...
Vax benefits outweigh risks of extremely rare potential side effects: AstraZeneca
Investing.com· 4 days agoNew Delhi, April 30 (IANS) Benefits of the Covid-19 vaccine far outweigh the risks of extremely rare...
Coroner issues warning after man, 28, given fatal Covid jab because of GP data blunder
Daily Telegraph· 4 days agoOn March 21 2021, Mr Reid was given his first dose of the OxfordAstraZeneca vaccine. Mr Longstaff...
Astrazeneca plc ADR (AZN) Has A Gold Mine On Its Hands – Stocks Register
Stocks Register· 2 days agoAstrazeneca plc ADR (NASDAQ:AZN) at last check was buoying at $76.06 on Thursday, May 02, with a fall of -0.46% from its closing price on previous day. Taking a look at stock ...
Safe and Effective? The New York Times Revisits the COVID Jab. - The American Spectator | USA News...
American Spectator· 8 hours agoIt has taken three years, but the New York Times has finally admitted that maybe, just maybe, there are some serious side effects to COVID vaccines. AstraZeneca, which has ...
Why selling to Novartis made sense for Mariana
BioPharma Dive via Yahoo Finance· 23 hours agoThat distinguishes its deal with Novartis from other recent acquisitions of RayzeBio by Bristol Myers Squibb and of Fusion Pharmaceuticals by AstraZeneca...
